The most efficient way to measure your GLP-1 analogs’ levels using ELISA assays
Glucagon-like peptide-1 agonist (GLP-1 agonist) is a class of drugs that reduce blood glucose and energy intake by activating the GLP-1 receptor. They mimic the actions of the endogenous incretin hormone GLP-1, which is released from the gut after eating. GLP-1 is the target of many synthetic drugs on the market, initially developed in the treatment of type II diabetes, including:
Liraglutide: Reduces meal-related hyperglycemia by delaying gastric emptying
Dulaglutide: Acts similarly to GLP-1, increasing the amount of insulin released by the pancreas
Lixisenatide: Helps the beta cells of the pancreas to secrete insulin in response to high blood sugar
Semaglutide: GLP-1 receptor agonist used to improve glycemic control in type 2 diabetes mellitus
At BMA, we offer competitive ELISA kits for the determination of GLP-1 analogs. Check out our catalog at www.bma.ch and get in contact with us at info@bma.ch We will be happy to assist you!
Your BMA Team
Author: Dr. Sonia Accossato
Copyright © BMA Biomedicals 2023